Publications by authors named "L Petraccia"
Background: The health of the marginalized populations is crucial for public health and inequalities. The World Health Organization (WHO) Global Hepatitis Report 2024 stated that over 304 million people were living with Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) infection in 2022. We performed HBV/HCV screenings among marginalized communities to reveal hidden infections and link-to-care positive participants.
View Article and Find Full Text PDFArticle Synopsis
- Medication poisoning is a leading method of self-harm, with long-term studies needed to assess its mental health impact, especially post-COVID-19.
- From 2018 to 2022, 756 self-harm cases were reviewed, showing a dip in 2020, but cases returned to pre-pandemic levels by 2021, with an increase in single-medication poisonings, particularly among youth aged 12-21.
- Acetaminophen was the most common medication involved, and the findings suggest that young people with psychiatric issues are increasingly vulnerable, prompting a call for better mental health support and counseling in at-risk populations.
Purpose: Mixed cryoglobulinemia syndrome (MCs) is a rare immunoproliferative systemic disorder with cutaneous and multiple organ involvement. Our multicenter survey study aimed to investigate the prevalence and outcome of COVID-19 and the safety and immunogenicity of COVID-19 vaccines in a large MCs series.
Methods: The survey included 430 unselected MCs patients (130 M, 300 F; mean age 70 ± 10.
Objective: Hepatitis C virus (HCV) causes neuropsychiatric disorders and quality of life impairment, especially in patients with cryoglobulinemic vasculitis (CV). Direct acting antivirals (DAAs) are effective in most extrahepatic HCV diseases, but limited information exists regarding the outcome of psychiatric disorders in patients with and without CV, after therapy. We aimed to evaluate psychiatric outcomes, in HCV-patients with and without CV, before and after successful DAA therapy.
View Article and Find Full Text PDF